Table 3.
Press-Ganey LTR | ||||||||
---|---|---|---|---|---|---|---|---|
Subspecialty | Phase 0 Jan 2019–Dec 2019 |
Phase 1 Jan 2020–Feb 2020 |
Phase 2 Mar 2020 - Apr 2020 |
Phase 3 May 2020–Aug 2020 |
P-value Phase 0 to Phase 1 |
P Value Phase 0 to Phase 2 |
P Value Phase 0 to Phase 3 |
P Value Phase 2 to Phase 3 |
Spine | 84.4% ± 36.2% | 90.1% ± 29.9% | 91.3% ± 28.5% | 87.3% ± 33.5% | 0.1 | 0.21 | 0.45 | 0.48 |
Tumor | 88.1% ± 32.4% | 87.7% ± 33.1% | 85.7% ± 35.6% | 81% ± 39.6% | 0.92 | 0.71 | 0.12 | 0.59 |
Vascular | 87.9% ± 32.7% | 87.5% ± 33.8% | 85.7% ± 36.3% | 92.6% ± 26.7% | 0.96 | 0.81 | 0.49 | 0.49 |
Functional | 91.1% ± 28.6% | 81.8% ± 39.5% | 100% ± 0% | 88.9% ± 32.3% | 0.19 | 0.35 | 0.77 | 0.32 |
Peripheral Nerve | 95.1% ± 21.7% | 100% ± 0% | 85.7% ± 36.3% | 95% ± 22.4% | 0.58 | 0.17 | 0.99 | 0.36 |
Trauma | 90.9% ± 30.2% | 100% ± 0% | 0.69 | |||||
Total | 87.3% ± 33.3% | 88.7% ± 31.7% | 89.2% ± 31.2% | 87% ± 33.8% | 0.54 | 0.56 | 0.9 | 0.56 |